Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Stericycle Inc.'s Stock Is Getting Shredded Today

By Matthew DiLallo - Apr 29, 2016 at 12:27PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The medical waste disposal specialist is pushing back the timeline for capturing revenue synergies from Shred-it.

Stericycle's stock today. Image source: Flickr user Mike Haw.

What: Shares of Stericycle (SRCL 0.85%) were down as much as 20% by 10:30 a.m. ET on Friday after the company reported lackluster first-quarter earnings.

So what: While Stericycle's revenue grew at a brisk pace, up 31.8% year over year, and 35.4% on a constant currency basis, earnings did not grow. Instead, earnings actually fell 3.4% to $1.10 per share. That's due to continued weak industrial hazardous waste revenue as well as a delay in capturing the expected synergies from the company's Shred-it acquisition.

COO Brent Arnold noted the integration issue on the company's conference call:

[...] We have reassessed the original timeline associated with the reroutes and onsite-to-offsite conversions. While several regions have successfully made this conversion, the time to convert each region is taking longer than previously anticipated. In order to ensure high service levels and support ongoing new customer growth, we have decided to extend the rollout schedule going forward. 

This delay will result in $20 million of expected synergies being pushed into 2017, with the full impact not being felt until 2018. That said, the company remains confident it will achieve the full synergies.

However, with this pushed-back time frame, the company needs to adjust its guidance for the full year. It now sees revenue in the range of $3.6 billion to $3.66 billion, down from its prior outlook for revenue of $3.65 billion to $3.74 billion. Earnings guidance, likewise, is coming down, in the range of $4.90-$5.05 per share, as opposed to $5.28-$5.35 per share.

Now what: On the one hand, Stericycle is putting its customers over profit, which isn't necessarily a bad long-term move. However, for an acquisition-driven company, it should have integration down to a science, which implies it might have bitten off a bit more than it could chew with Shred-it. The market clearly is concerned that this deal might not deliver the earnings power that Stericycle envisioned when it announced the transaction. Now, it needs to redouble its integration efforts to ensure that this deal does deliver as expected.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Stericycle, Inc. Stock Quote
Stericycle, Inc.
$49.94 (0.85%) $0.42

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.